|
|
||||||||
Stem Cells, Vol 11, 228-234, Copyright © 1993 by AlphaMed Press
ORIGINAL ARTICLES |
H Toda, A Murata, N Matsuura, K Uda, Y Oka, N Tanaka and T Mori
Department of Surgery II, Osaka University Medical School, Japan.
To identify the therapeutic efficacy of granulocyte colony stimulating factor (G-CSF) in severe sepsis, we examined its effect on the mortality and pathological changes in vital organs using the rat lethal sepsis model. Rats were given 15 micrograms of recombinant human (rh)G- CSF after the onset of peritonitis brought about by cecal ligation and puncture. The mortality rate after 72 h was significantly decreased by administration of 15 micrograms of rhG-CSF (p < 0.001). In addition, the administration of rhG-CSF induced an improvement in liver and renal functions. It also produced marked pathological improvement in the lungs. These results strongly indicated that administration of rhG-CSF, even after the onset of sepsis, was effective in decreasing the mortality from peritonitis-induced multiple organ failure, and this finding was clearly useful in the clinical treatment of such sepsis- induced critical illness.
This article has been cited by other articles:
![]() |
A. C. Cheng and B. J. Currie Melioidosis: Epidemiology, Pathophysiology, and Management Clin. Microbiol. Rev., April 1, 2005; 18(2): 383 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rodgers, S. Xiong, T. Espinoza, N. Roda, S. Maldonado, and G. S. diZerega Angiotensin II Increases Host Resistance to Peritonitis Clin. Vaccine Immunol., July 1, 2000; 7(4): 635 - 640. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
